Gut Microbiome in Chronic Coronary Syndrome Patients

Despite knowledge of classical coronary artery disease (CAD) risk factors, the morbidity and mortality associated with this disease remain high. Therefore, new factors that may affect the development of CAD, such as the gut microbiome, are extensively investigated. This study aimed to evaluate gut m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emilia Sawicka-Smiarowska, Kinga Bondarczuk, Witold Bauer, Magdalena Niemira, Anna Szalkowska, Justyna Raczkowska, Miroslaw Kwasniewski, Ewa Tarasiuk, Marlena Dubatowka, Magda Lapinska, Malgorzata Szpakowicz, Zofia Stachurska, Anna Szpakowicz, Pawel Sowa, Andrzej Raczkowski, Marcin Kondraciuk, Magdalena Gierej, Joanna Motyka, Jacek Jamiolkowski, Mateusz Bondarczuk, Malgorzata Chlabicz, Jolanta Bucko, Marcin Kozuch, Slawomir Dobrzycki, Jerzy Bychowski, Wlodzimierz Jerzy Musial, Adrian Godlewski, Michal Ciborowski, Attila Gyenesei, Adam Kretowski, Karol Adam Kaminski
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/9fbe5c938b9346fd981eb0048f6566c1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9fbe5c938b9346fd981eb0048f6566c1
record_format dspace
spelling oai:doaj.org-article:9fbe5c938b9346fd981eb0048f6566c12021-11-11T17:41:50ZGut Microbiome in Chronic Coronary Syndrome Patients10.3390/jcm102150742077-0383https://doaj.org/article/9fbe5c938b9346fd981eb0048f6566c12021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5074https://doaj.org/toc/2077-0383Despite knowledge of classical coronary artery disease (CAD) risk factors, the morbidity and mortality associated with this disease remain high. Therefore, new factors that may affect the development of CAD, such as the gut microbiome, are extensively investigated. This study aimed to evaluate gut microbiome composition in CAD patients in relation to the control group. We examined 169 CAD patients and 166 people in the control group, without CAD, matched in terms of age and sex to the study group. Both populations underwent a detailed health assessment. The microbiome analysis was based on the V3–V4 region of the 16S rRNA gene (NGS method). Among 4074 identified taxonomic units in the whole population, 1070 differed between study groups. The most common bacterial types were <i>Firmicutes</i>, <i>Bacteroidetes</i>, <i>Proteobacteria,</i> and <i>Actinobacteria</i>. Furthermore, a higher <i>Firmicutes/Bacteroidetes</i> ratio in the CAD group compared with the control was demonstrated. <i>Firmicutes/Bacteroidetes</i> ratio, independent of age, sex, CAD status, LDL cholesterol concentration, and statins treatment, was related to altered phosphatidylcholine concentrations obtained in targeted metabolomics. Altered alpha-biodiversity (Kruskal–Wallis test, <i>p</i> = 0.001) and beta-biodiversity (Bray–Curtis metric, <i>p</i> < 0.001) in the CAD group were observed. Moreover, a predicted functional analysis revealed some taxonomic units, metabolic pathways, and proteins that might be characteristic of the CAD patients’ microbiome, such as increased expressions of 6-phospho-β-glucosidase and protein-N(pi)-phosphohistidine-sugar phosphotransferase and decreased expressions of DNA topoisomerase, oxaloacetate decarboxylase, and 6-beta-glucosidase. In summary, CAD is associated with altered gut microbiome composition and function.Emilia Sawicka-SmiarowskaKinga BondarczukWitold BauerMagdalena NiemiraAnna SzalkowskaJustyna RaczkowskaMiroslaw KwasniewskiEwa TarasiukMarlena DubatowkaMagda LapinskaMalgorzata SzpakowiczZofia StachurskaAnna SzpakowiczPawel SowaAndrzej RaczkowskiMarcin KondraciukMagdalena GierejJoanna MotykaJacek JamiolkowskiMateusz BondarczukMalgorzata ChlabiczJolanta BuckoMarcin KozuchSlawomir DobrzyckiJerzy BychowskiWlodzimierz Jerzy MusialAdrian GodlewskiMichal CiborowskiAttila GyeneseiAdam KretowskiKarol Adam KaminskiMDPI AGarticlegut microbiomecoronary artery disease<i>Firmicutes/Bacteroidetes</i> ratiomicrobiome dysbiosistargeted metabolomicsphosphatidylcholineMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5074, p 5074 (2021)
institution DOAJ
collection DOAJ
language EN
topic gut microbiome
coronary artery disease
<i>Firmicutes/Bacteroidetes</i> ratio
microbiome dysbiosis
targeted metabolomics
phosphatidylcholine
Medicine
R
spellingShingle gut microbiome
coronary artery disease
<i>Firmicutes/Bacteroidetes</i> ratio
microbiome dysbiosis
targeted metabolomics
phosphatidylcholine
Medicine
R
Emilia Sawicka-Smiarowska
Kinga Bondarczuk
Witold Bauer
Magdalena Niemira
Anna Szalkowska
Justyna Raczkowska
Miroslaw Kwasniewski
Ewa Tarasiuk
Marlena Dubatowka
Magda Lapinska
Malgorzata Szpakowicz
Zofia Stachurska
Anna Szpakowicz
Pawel Sowa
Andrzej Raczkowski
Marcin Kondraciuk
Magdalena Gierej
Joanna Motyka
Jacek Jamiolkowski
Mateusz Bondarczuk
Malgorzata Chlabicz
Jolanta Bucko
Marcin Kozuch
Slawomir Dobrzycki
Jerzy Bychowski
Wlodzimierz Jerzy Musial
Adrian Godlewski
Michal Ciborowski
Attila Gyenesei
Adam Kretowski
Karol Adam Kaminski
Gut Microbiome in Chronic Coronary Syndrome Patients
description Despite knowledge of classical coronary artery disease (CAD) risk factors, the morbidity and mortality associated with this disease remain high. Therefore, new factors that may affect the development of CAD, such as the gut microbiome, are extensively investigated. This study aimed to evaluate gut microbiome composition in CAD patients in relation to the control group. We examined 169 CAD patients and 166 people in the control group, without CAD, matched in terms of age and sex to the study group. Both populations underwent a detailed health assessment. The microbiome analysis was based on the V3–V4 region of the 16S rRNA gene (NGS method). Among 4074 identified taxonomic units in the whole population, 1070 differed between study groups. The most common bacterial types were <i>Firmicutes</i>, <i>Bacteroidetes</i>, <i>Proteobacteria,</i> and <i>Actinobacteria</i>. Furthermore, a higher <i>Firmicutes/Bacteroidetes</i> ratio in the CAD group compared with the control was demonstrated. <i>Firmicutes/Bacteroidetes</i> ratio, independent of age, sex, CAD status, LDL cholesterol concentration, and statins treatment, was related to altered phosphatidylcholine concentrations obtained in targeted metabolomics. Altered alpha-biodiversity (Kruskal–Wallis test, <i>p</i> = 0.001) and beta-biodiversity (Bray–Curtis metric, <i>p</i> < 0.001) in the CAD group were observed. Moreover, a predicted functional analysis revealed some taxonomic units, metabolic pathways, and proteins that might be characteristic of the CAD patients’ microbiome, such as increased expressions of 6-phospho-β-glucosidase and protein-N(pi)-phosphohistidine-sugar phosphotransferase and decreased expressions of DNA topoisomerase, oxaloacetate decarboxylase, and 6-beta-glucosidase. In summary, CAD is associated with altered gut microbiome composition and function.
format article
author Emilia Sawicka-Smiarowska
Kinga Bondarczuk
Witold Bauer
Magdalena Niemira
Anna Szalkowska
Justyna Raczkowska
Miroslaw Kwasniewski
Ewa Tarasiuk
Marlena Dubatowka
Magda Lapinska
Malgorzata Szpakowicz
Zofia Stachurska
Anna Szpakowicz
Pawel Sowa
Andrzej Raczkowski
Marcin Kondraciuk
Magdalena Gierej
Joanna Motyka
Jacek Jamiolkowski
Mateusz Bondarczuk
Malgorzata Chlabicz
Jolanta Bucko
Marcin Kozuch
Slawomir Dobrzycki
Jerzy Bychowski
Wlodzimierz Jerzy Musial
Adrian Godlewski
Michal Ciborowski
Attila Gyenesei
Adam Kretowski
Karol Adam Kaminski
author_facet Emilia Sawicka-Smiarowska
Kinga Bondarczuk
Witold Bauer
Magdalena Niemira
Anna Szalkowska
Justyna Raczkowska
Miroslaw Kwasniewski
Ewa Tarasiuk
Marlena Dubatowka
Magda Lapinska
Malgorzata Szpakowicz
Zofia Stachurska
Anna Szpakowicz
Pawel Sowa
Andrzej Raczkowski
Marcin Kondraciuk
Magdalena Gierej
Joanna Motyka
Jacek Jamiolkowski
Mateusz Bondarczuk
Malgorzata Chlabicz
Jolanta Bucko
Marcin Kozuch
Slawomir Dobrzycki
Jerzy Bychowski
Wlodzimierz Jerzy Musial
Adrian Godlewski
Michal Ciborowski
Attila Gyenesei
Adam Kretowski
Karol Adam Kaminski
author_sort Emilia Sawicka-Smiarowska
title Gut Microbiome in Chronic Coronary Syndrome Patients
title_short Gut Microbiome in Chronic Coronary Syndrome Patients
title_full Gut Microbiome in Chronic Coronary Syndrome Patients
title_fullStr Gut Microbiome in Chronic Coronary Syndrome Patients
title_full_unstemmed Gut Microbiome in Chronic Coronary Syndrome Patients
title_sort gut microbiome in chronic coronary syndrome patients
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/9fbe5c938b9346fd981eb0048f6566c1
work_keys_str_mv AT emiliasawickasmiarowska gutmicrobiomeinchroniccoronarysyndromepatients
AT kingabondarczuk gutmicrobiomeinchroniccoronarysyndromepatients
AT witoldbauer gutmicrobiomeinchroniccoronarysyndromepatients
AT magdalenaniemira gutmicrobiomeinchroniccoronarysyndromepatients
AT annaszalkowska gutmicrobiomeinchroniccoronarysyndromepatients
AT justynaraczkowska gutmicrobiomeinchroniccoronarysyndromepatients
AT miroslawkwasniewski gutmicrobiomeinchroniccoronarysyndromepatients
AT ewatarasiuk gutmicrobiomeinchroniccoronarysyndromepatients
AT marlenadubatowka gutmicrobiomeinchroniccoronarysyndromepatients
AT magdalapinska gutmicrobiomeinchroniccoronarysyndromepatients
AT malgorzataszpakowicz gutmicrobiomeinchroniccoronarysyndromepatients
AT zofiastachurska gutmicrobiomeinchroniccoronarysyndromepatients
AT annaszpakowicz gutmicrobiomeinchroniccoronarysyndromepatients
AT pawelsowa gutmicrobiomeinchroniccoronarysyndromepatients
AT andrzejraczkowski gutmicrobiomeinchroniccoronarysyndromepatients
AT marcinkondraciuk gutmicrobiomeinchroniccoronarysyndromepatients
AT magdalenagierej gutmicrobiomeinchroniccoronarysyndromepatients
AT joannamotyka gutmicrobiomeinchroniccoronarysyndromepatients
AT jacekjamiolkowski gutmicrobiomeinchroniccoronarysyndromepatients
AT mateuszbondarczuk gutmicrobiomeinchroniccoronarysyndromepatients
AT malgorzatachlabicz gutmicrobiomeinchroniccoronarysyndromepatients
AT jolantabucko gutmicrobiomeinchroniccoronarysyndromepatients
AT marcinkozuch gutmicrobiomeinchroniccoronarysyndromepatients
AT slawomirdobrzycki gutmicrobiomeinchroniccoronarysyndromepatients
AT jerzybychowski gutmicrobiomeinchroniccoronarysyndromepatients
AT wlodzimierzjerzymusial gutmicrobiomeinchroniccoronarysyndromepatients
AT adriangodlewski gutmicrobiomeinchroniccoronarysyndromepatients
AT michalciborowski gutmicrobiomeinchroniccoronarysyndromepatients
AT attilagyenesei gutmicrobiomeinchroniccoronarysyndromepatients
AT adamkretowski gutmicrobiomeinchroniccoronarysyndromepatients
AT karoladamkaminski gutmicrobiomeinchroniccoronarysyndromepatients
_version_ 1718432015755247616